Filter Results:
(63)
Show Results For
- All HBS Web
(934)
- People (2)
- News (63)
- Research (769)
- Events (1)
- Multimedia (2)
- Faculty Publications (661)
Show Results For
- All HBS Web
(934)
- People (2)
- News (63)
- Research (769)
- Events (1)
- Multimedia (2)
- Faculty Publications (661)
Page 1 of 63
Results →
Sort by
- 01 Mar 2011
- News
Fixing What Ails the Drug Industry
at the 11th HBS Health Industry Alumni Association Conference. She joined Eli Lilly CEO John Lechleiter in addressing the November 4–6 event, titled “The Future of Therapy from the Leaders Who Create It.” So what’s the cure for the ailing... View Details
- 01 Feb 2002
- News
Health Industry Alumni Convene for Conference
in the knowledge-based biotechnology industry to forge balanced partnership deals with the financially much stronger pharmaceutical industry." A panel led by HBS associate professor Jonathan West discussed... View Details
- 01 Mar 2007
- News
Daniel Vasella
sales of $37 billion. The company’s aggressive investment in research has made it an industry leader in new drug approvals. And when opportunity knocks, Vasella doesn’t hesitate to broaden Novartis’s business mix through acquisitions. He... View Details
- 15 Sep 2016
- News
Price of pharma innovation: Pro
- 01 Aug 2006
- News
Big Pharma's Prognosis
- 15 Feb 2011
- News
Who will blink in Genzyme, Sanofi price talks?
- 26 Apr 2010
- News
Pharma's Future Depends on These Three Trends
- 01 Jun 2024
- News
Quantum Leap
pharmaceutical and chemical industries have taken note: The venture capital arm of the pharma giant Merck, for instance, invested $5 million in SEEQC’s Series A round, where it was joined by the South Korean... View Details
- 01 Feb 1999
- News
Too Much of a Good Thing?
years, sectors as diverse as automobiles, semiconductors, steel, textiles, consumer electronics, tires, and pharmaceuticals have been afflicted by overcapacity and some or all of its unpleasant side effects: loss of jobs, plant closings,... View Details
Keywords: Garry Emmons
- 01 Sep 2007
- News
Alfred D. Chandler Jr. Remembered
Matsushita. That volume was followed in 2005 by Shaping the Industrial Century: The Remarkable Story of the Evolution of the Modern Chemical and Pharmaceutical Industries. “Such science-based View Details
- 01 Dec 2019
- News
Remix
community after their respective accusations against Clarence Thomas and Mike Tyson. It’s one of the factors that helps explain why women of color report sexual assault at rates far below that of white women and a major force behind Dixon’s decision to leave the View Details
- 01 Oct 2001
- News
Guy de Chazal: Changing Focus
venture capital with Citicorp. "The industry was much, much smaller in those days," he says. "A few hundred million dollars a year, versus almost a hundred billion today." Drawing on his experience with Morgan Stanley since 1986, he... View Details
Keywords: Deborah Blagg
- 31 Jan 2014
- News
Body, Heal Thyself
for the development and exclusive use of the mRNA technology to treat cardiovascular, renal, and metabolic diseases as well as cancer. "It is one of the largest-ever initial payments in a pharmaceutical View Details
- 01 Mar 2003
- News
Inside the Revolution
humanity discovered how to use fire,” says Enriquez’s colleague, HBS associate professor Jonathan West. West, who had been researching the semiconductor industry for some ten years, came to the life sciences field rather recently.... View Details
- 01 Jun 2000
- News
The Business of Biotech
is not a postdoc lab, this is a business. It's not enough just to do the experiment; somebody's got to take the ball and run with it." Lately, competition in the biotech industry has become more heated than ever, as a steadily increasing... View Details
Keywords: Julia Hanna
- 01 Dec 2003
- News
The Next Big Thing
life-sciences center of the world, by virtue of its unsurpassed “cluster” of world-renowned universities and teaching hospitals; medical-device, biotech, and pharmaceutical companies; financial firms; and skilled workers. “The leadership... View Details
- 01 Dec 2013
- News
Your Own Medicine
help build new muscle—had been one of several potential treatments the Secklers chased to no avail, often stuck following promising science to dead ends. That changed three years ago, when former pharmaceutical executive Gene Williams... View Details